Senaste nyheterna Gedea Biotech Announces CE-Marking for pHyph: A Novel Antibiotic-Free Treatment for Bacterial VaginosisGedea Biotech Announces CE-Marking for pHyph: A Novel Antibiotic-Free Treatment for Bacterial Vaginosis 2 September 2025PRESS RELEASE Gedea Biotech Receives US Patent for Preventing Preterm BirthGedea Biotech announced today that the United States Patent and Trademark Office (USPTO) has granted the company’s…27 March 2025Gedea Biotech Reports Significant Results in Study for the Treatment of Bacterial Vaginosis12 March 2025Closing the Health GapOn the Iternational Women's Day we want to address the THE WOMEN’S HEALTH GAP 8 March 2025Gedea wins prestigious scale up awardOn Thursday November 28th, at the Nordic Mentor Network For Entrepreneurship - NOME annual meeting in Copenhagen, we…3 December 2024Emilia, industrial doctoral student at Gedea and Karolinska InstitutetEmilia Lahtinen is an industrial Ph.D. student at Gedea and at Karolinska Institutet. Her project has the title…3 December 2024Anna-Karin Areskog strengthens the teamGedea has recently strengthened its team by hiring Anna-Karin Areskog as QA Director. Anna-Karin has been a consultant…3 December 2024 Press kitKlicka för att ladda ner logotyper och bilder
